These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25859460)

  • 21. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland.
    Nagel H; Laskawi R; Wahlers A; Hemmerlein B
    Histopathology; 2004 Mar; 44(3):222-31. PubMed ID: 14987225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of diagnostic utility of imprint cytology in paediatric renal tumours with special references to Ki 67 proliferative marker.
    Maity N; Das C; Mukhopadhyay M; Parvin T; Saha AK; Mukhopadhyay B
    J Lab Physicians; 2018; 10(4):437-442. PubMed ID: 30498318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-flow cytometry, DNA-image cytometry and proliferation index (MIB-5) in irradiated rat salivary glands and salivary gland tumors.
    Friedrich RE; Hieke N; Stern C; Lautenschläger C; Holzhausen HJ; Caselitz J; Bartel-Friedrich S
    In Vivo; 2004; 18(2):213-22. PubMed ID: 15113049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear hBD-1 accumulation in malignant salivary gland tumours.
    Wenghoefer M; Pantelis A; Dommisch H; Götz W; Reich R; Bergé S; Martini M; Allam JP; Jepsen S; Merkelbach-Bruse S; Fischer HP; Novak N; Winter J
    BMC Cancer; 2008 Oct; 8():290. PubMed ID: 18840281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoexpression of hoxb7 and hoxb9 in salivary gland tumours.
    Fonseca FP; Bingle L; Santos-Silva AR; Lopes MA; Coletta RD; de Andrade BA; Mariano FV; Kowalski LP; Rangel AL; Martins MD; Meurer L; Hunter KD; Speight PM; Vargas PA
    J Oral Pathol Med; 2016 Oct; 45(9):672-681. PubMed ID: 26991799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal Tumours in Adults with Correlation between Fuhrman Grading and Proliferative Marker.
    Mukhopadhyay SG; Mukherjee K; Kr Manna A
    Iran J Pathol; 2015; 10(4):281-9. PubMed ID: 26351498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Migration-stimulating factor as a novel biomarker in salivary gland tumours.
    Aljorani LE; Bankfalvi A; Carey FA; Harada K; Ohe G; Jones SJ; Ellis IR; Schor SL; Schor AM
    J Oral Pathol Med; 2011 Nov; 40(10):747-54. PubMed ID: 21481007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical detection of XIAP in mesothelium and mesothelial lesions.
    Wu M; Sun Y; Li G; Desman G; Wang B; Gil J; Burstein DE
    Am J Clin Pathol; 2007 Nov; 128(5):783-7. PubMed ID: 17951200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ki 67 expression in 35 borderline ovarian tumours: relations with clinicopathologic parameters and ploidy.
    Darai E; Walker-Combrouze F; Dauge-Geoffroy MC; Vincent Y; Feldmann G; Madelenat P; Scoazec JY
    Eur J Obstet Gynecol Reprod Biol; 1998 Feb; 76(2):175-80. PubMed ID: 9481570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The equilibrium of XIAP and Smac/DIABLO expression is gradually deranged during the development and progression of testicular germ cell tumours.
    Kempkensteffen C; Jäger T; Bub J; Weikert S; Hinz S; Christoph F; Krause H; Schostak M; Miller K; Schrader M
    Int J Androl; 2007 Oct; 30(5):476-83. PubMed ID: 17298543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The significance of Ki-67 antigen expression in the distinction between benign and malignant pheochromocytomas].
    Feng C; Li HZ; Yan WG; Gao JG; Xu WF; Luo YF; Cao JL
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1697-700. PubMed ID: 18476530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proliferation marker Chromatin Assembly Factor-1 is of clinical value in predicting the biological behaviour of salivary gland tumours.
    Staibano S; Mascolo M; Rocco A; Lo Muzio L; Ilardi G; Siano M; Pannone G; Vecchione ML; Nugnes L; Califano L; Zamparese R; Bufo P; De Rosa G
    Oncol Rep; 2011 Jan; 25(1):13-22. PubMed ID: 21109952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial ovarian tumors: Clinicopathological correlation and immunohistochemical study.
    Naik PS; Deshmukh S; Khandeparkar SG; Joshi A; Babanagare S; Potdar J; Risbud NS
    J Midlife Health; 2015; 6(4):178-83. PubMed ID: 26903759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.
    Nagel H; Laskawi R; Eiffert H; Schlott T
    Mol Pathol; 2003 Aug; 56(4):226-31. PubMed ID: 12890744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
    Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
    Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?
    van der Harst E; Bruining HA; Jaap Bonjer H; van der Ham F; Dinjens WN; Lamberts SW; de Herder WW; Koper JW; Stijnen T; Proye C; Lecomte-Houcke M; Bosman FT; de Krijger RR
    J Pathol; 2000 Jun; 191(2):175-80. PubMed ID: 10861578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical expression of Bcl-2 in benign and malignant salivary gland tumors.
    Manjunatha BS; Kumar GS; Raghunath V
    Med Oral Patol Oral Cir Bucal; 2011 Jul; 16(4):e503-7. PubMed ID: 21196881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours.
    Fauvet R; Dufournet C; Poncelet C; Uzan C; Hugol D; Daraï E
    J Surg Oncol; 2005 Dec; 92(4):337-43. PubMed ID: 16299808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulated expression of p16INK4a and p53 pathway members in benign and malignant myoepithelial tumours of the salivary glands.
    Vékony H; Röser K; Löning T; Raaphorst FM; Leemans CR; Van der Waal I; Bloemena E
    Histopathology; 2008 Dec; 53(6):658-66. PubMed ID: 19076682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.